Neogen Corporation (NEOG)
USD 11.64
(-4.04%)
USD 11.64
(-4.04%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | 58.66 Million USD | 56.37% |
| 2023 | 37.51 Million USD | 7.42% |
| 2022 | 34.92 Million USD | -34.26% |
| 2021 | 53.12 Million USD | 8.14% |
| 2020 | 49.12 Million USD | -2.66% |
| 2019 | 50.47 Million USD | -28.1% |
| 2018 | 70.19 Million USD | 8.08% |
| 2017 | 64.94 Million USD | 15.18% |
| 2016 | 56.38 Million USD | 6.15% |
| 2015 | 53.11 Million USD | 22.42% |
| 2014 | 43.39 Million USD | 6.6% |
| 2013 | 40.7 Million USD | 20.65% |
| 2012 | 33.73 Million USD | -5.85% |
| 2011 | 35.83 Million USD | 33.32% |
| 2010 | 26.87 Million USD | 31.19% |
| 2009 | 20.48 Million USD | 13.7% |
| 2008 | 18.01 Million USD | 33.43% |
| 2007 | 13.5 Million USD | 12.11% |
| 2006 | 12.04 Million USD | 37.36% |
| 2005 | 8.76 Million USD | 16.27% |
| 2004 | 7.54 Million USD | 11.16% |
| 2003 | 6.78 Million USD | 23.36% |
| 2002 | 5.5 Million USD | 28.96% |
| 2001 | 4.26 Million USD | 80.49% |
| 2000 | 2.36 Million USD | -9.12% |
| 1999 | 2.6 Million USD | 62.5% |
| 1998 | 1.6 Million USD | 14.29% |
| 1997 | 1.4 Million USD | 180.0% |
| 1996 | 500 Thousand USD | -16.67% |
| 1995 | 600 Thousand USD | -33.33% |
| 1994 | 900 Thousand USD | 228.57% |
| 1993 | -700 Thousand USD | 30.0% |
| 1992 | -1 Million USD | 16.67% |
| 1991 | -1.2 Million USD | -20.0% |
| 1990 | -1 Million USD | -400.0% |
| 1989 | -200 Thousand USD | 75.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 12.02 Million USD | -16.88% |
| 2024 Q2 | 14.46 Million USD | -24.41% |
| 2024 Q4 | 17.57 Million USD | 46.15% |
| 2024 Q1 | 19.13 Million USD | -18.31% |
| 2024 FY | 77.42 Million USD | 106.39% |
| 2023 Q1 | 6.06 Million USD | -50.17% |
| 2023 Q2 | -7.65 Million USD | -226.29% |
| 2023 FY | 37.51 Million USD | 7.42% |
| 2023 Q3 | -11.78 Million USD | -53.96% |
| 2023 Q4 | 23.42 Million USD | 298.74% |
| 2022 Q3 | 55 Thousand USD | -99.56% |
| 2022 Q1 | 21.74 Million USD | 7.36% |
| 2022 Q4 | 12.16 Million USD | 22020.0% |
| 2022 FY | 34.92 Million USD | -34.26% |
| 2022 Q2 | 12.46 Million USD | -42.66% |
| 2021 Q3 | 15.77 Million USD | -18.04% |
| 2021 FY | 53.12 Million USD | 8.14% |
| 2021 Q4 | 20.25 Million USD | 28.41% |
| 2021 Q2 | 19.24 Million USD | 1.85% |
| 2021 Q1 | 18.89 Million USD | -5.26% |
| 2020 Q4 | 19.94 Million USD | 52.91% |
| 2020 FY | 49.12 Million USD | -2.66% |
| 2020 Q1 | 16.26 Million USD | -13.17% |
| 2020 Q2 | 18.27 Million USD | 12.35% |
| 2020 Q3 | 13.04 Million USD | -28.62% |
| 2019 Q2 | 18.24 Million USD | 10.72% |
| 2019 Q1 | 16.47 Million USD | -17.02% |
| 2019 Q4 | 18.73 Million USD | 27.95% |
| 2019 Q3 | 14.63 Million USD | -19.77% |
| 2019 FY | 50.47 Million USD | -28.1% |
| 2018 Q1 | 16.42 Million USD | -13.56% |
| 2018 Q4 | 19.85 Million USD | 24.8% |
| 2018 Q3 | 15.91 Million USD | -11.58% |
| 2018 Q2 | 17.99 Million USD | 9.58% |
| 2018 FY | 70.19 Million USD | 8.08% |
| 2017 Q2 | 16.85 Million USD | 14.31% |
| 2017 FY | 64.94 Million USD | 15.18% |
| 2017 Q3 | 14.35 Million USD | -14.84% |
| 2017 Q4 | 19 Million USD | 32.39% |
| 2017 Q1 | 14.74 Million USD | -5.65% |
| 2016 FY | 56.38 Million USD | 6.15% |
| 2016 Q4 | 15.62 Million USD | 38.84% |
| 2016 Q1 | 14.89 Million USD | 1.87% |
| 2016 Q2 | 14.61 Million USD | -1.9% |
| 2016 Q3 | 11.25 Million USD | -22.98% |
| 2015 FY | 53.11 Million USD | 22.42% |
| 2015 Q4 | 14.62 Million USD | 20.25% |
| 2015 Q2 | 12.89 Million USD | -4.03% |
| 2015 Q3 | 12.16 Million USD | -5.71% |
| 2015 Q1 | 13.43 Million USD | 22.27% |
| 2014 Q3 | 10.29 Million USD | 6.23% |
| 2014 FY | 43.39 Million USD | 6.6% |
| 2014 Q1 | 12.41 Million USD | 21.33% |
| 2014 Q2 | 9.68 Million USD | -21.98% |
| 2014 Q4 | 10.99 Million USD | 6.78% |
| 2013 Q2 | 10.47 Million USD | 1.44% |
| 2013 Q4 | 10.23 Million USD | 5.89% |
| 2013 FY | 40.7 Million USD | 20.65% |
| 2013 Q1 | 10.32 Million USD | 18.75% |
| 2013 Q3 | 9.66 Million USD | -7.74% |
| 2012 Q2 | 8.14 Million USD | -12.91% |
| 2012 FY | 33.73 Million USD | -5.85% |
| 2012 Q4 | 8.69 Million USD | 15.21% |
| 2012 Q3 | 7.54 Million USD | -7.29% |
| 2012 Q1 | 9.35 Million USD | 9.42% |
| 2011 Q1 | 9.59 Million USD | 37.91% |
| 2011 Q2 | 9.62 Million USD | 0.34% |
| 2011 Q3 | 8.06 Million USD | -16.24% |
| 2011 Q4 | 8.54 Million USD | 5.95% |
| 2011 FY | 35.83 Million USD | 33.32% |
| 2010 Q4 | 6.95 Million USD | 21.03% |
| 2010 Q1 | 6.94 Million USD | 28.52% |
| 2010 Q2 | 7.22 Million USD | 4.09% |
| 2010 Q3 | 5.74 Million USD | -20.46% |
| 2010 FY | 26.87 Million USD | 31.19% |
| 2009 Q1 | 5.65 Million USD | 20.46% |
| 2009 FY | 20.48 Million USD | 13.7% |
| 2009 Q2 | 5.86 Million USD | 3.68% |
| 2009 Q3 | 3.57 Million USD | -39.07% |
| 2009 Q4 | 5.4 Million USD | 51.3% |
| 2008 Q3 | 3.98 Million USD | -17.03% |
| 2008 Q4 | 4.69 Million USD | 17.88% |
| 2008 FY | 18.01 Million USD | 33.43% |
| 2008 Q1 | 4.54 Million USD | 41.74% |
| 2008 Q2 | 4.79 Million USD | 5.52% |
| 2007 FY | 13.5 Million USD | 12.11% |
| 2007 Q4 | 3.2 Million USD | 6.15% |
| 2007 Q3 | 3.02 Million USD | -18.24% |
| 2007 Q2 | 3.69 Million USD | 3.3% |
| 2007 Q1 | 3.57 Million USD | 14.13% |
| 2006 Q1 | 3.1 Million USD | 42.37% |
| 2006 Q2 | 3.34 Million USD | 7.79% |
| 2006 Q3 | 2.45 Million USD | -26.56% |
| 2006 Q4 | 3.13 Million USD | 27.54% |
| 2006 FY | 12.04 Million USD | 37.36% |
| 2005 Q4 | 2.18 Million USD | 22.73% |
| 2005 Q3 | 1.77 Million USD | -25.37% |
| 2005 Q2 | 2.38 Million USD | -2.02% |
| 2005 Q1 | 2.43 Million USD | 49.72% |
| 2005 FY | 8.76 Million USD | 16.27% |
| 2004 Q1 | 1.87 Million USD | 4.4% |
| 2004 FY | 7.54 Million USD | 11.16% |
| 2004 Q4 | 1.62 Million USD | -8.05% |
| 2004 Q3 | 1.76 Million USD | -22.59% |
| 2004 Q2 | 2.28 Million USD | 21.66% |
| 2003 Q1 | 1.53 Million USD | 5.12% |
| 2003 Q2 | 2.03 Million USD | 32.29% |
| 2003 Q3 | 1.41 Million USD | -30.5% |
| 2003 Q4 | 1.79 Million USD | 26.86% |
| 2003 FY | 6.78 Million USD | 23.36% |
| 2002 Q1 | 1.23 Million USD | -9.59% |
| 2002 Q3 | 1.1 Million USD | -34.59% |
| 2002 Q4 | 1.46 Million USD | 32.13% |
| 2002 Q2 | 1.69 Million USD | 37.17% |
| 2002 FY | 5.5 Million USD | 28.96% |
| 2001 Q1 | 802 Thousand USD | 14.08% |
| 2001 Q2 | 1.16 Million USD | 44.64% |
| 2001 Q3 | 937 Thousand USD | -19.22% |
| 2001 Q4 | 1.36 Million USD | 45.78% |
| 2001 FY | 4.26 Million USD | 80.49% |
| 2000 Q1 | 600 Thousand USD | 50.0% |
| 2000 FY | 2.36 Million USD | -9.12% |
| 2000 Q4 | 703 Thousand USD | -2.9% |
| 2000 Q3 | 724 Thousand USD | 262.0% |
| 2000 Q2 | 200 Thousand USD | -66.67% |
| 1999 Q3 | 700 Thousand USD | -12.5% |
| 1999 FY | 2.6 Million USD | 62.5% |
| 1999 Q1 | 5.7 Million USD | 1800.0% |
| 1999 Q2 | 800 Thousand USD | -85.96% |
| 1999 Q4 | 400 Thousand USD | -42.86% |
| 1998 Q3 | 400 Thousand USD | 0.0% |
| 1998 Q4 | 300 Thousand USD | -25.0% |
| 1998 FY | 1.6 Million USD | 14.29% |
| 1998 Q2 | 400 Thousand USD | 0.0% |
| 1998 Q1 | 400 Thousand USD | 33.33% |
| 1997 Q2 | 400 Thousand USD | -20.0% |
| 1997 FY | 1.4 Million USD | 180.0% |
| 1997 Q4 | 300 Thousand USD | 0.0% |
| 1997 Q1 | 500 Thousand USD | -16.67% |
| 1997 Q3 | 300 Thousand USD | -25.0% |
| 1996 Q4 | 600 Thousand USD | 500.0% |
| 1996 FY | 500 Thousand USD | -16.67% |
| 1996 Q3 | 100 Thousand USD | 0.0% |
| 1996 Q2 | 100 Thousand USD | 0.0% |
| 1996 Q1 | - USD | 100.0% |
| 1995 Q1 | 2.6 Million USD | 136.62% |
| 1995 Q2 | 2.9 Million USD | 11.54% |
| 1995 Q3 | 3 Million USD | 3.45% |
| 1995 FY | 600 Thousand USD | -33.33% |
| 1995 Q4 | -8 Million USD | -366.67% |
| 1994 FY | 900 Thousand USD | 228.57% |
| 1994 Q2 | 400 Thousand USD | 300.0% |
| 1994 Q3 | 2.7 Million USD | 575.0% |
| 1994 Q4 | -7.1 Million USD | -362.96% |
| 1994 Q1 | 100 Thousand USD | 101.64% |
| 1993 FY | -700 Thousand USD | 30.0% |
| 1993 Q4 | -6.1 Million USD | -390.48% |
| 1993 Q3 | 2.1 Million USD | 10.53% |
| 1993 Q2 | 1.9 Million USD | 733.33% |
| 1993 Q1 | -300 Thousand USD | 94.83% |
| 1992 Q4 | -5.8 Million USD | -422.22% |
| 1992 FY | -1 Million USD | 16.67% |
| 1992 Q3 | 1.8 Million USD | 5.88% |
| 1992 Q2 | 1.7 Million USD | 30.77% |
| 1992 Q1 | 1.3 Million USD | 124.53% |
| 1991 Q2 | 1.5 Million USD | 36.36% |
| 1991 Q3 | 1.5 Million USD | 0.0% |
| 1991 FY | -1.2 Million USD | -20.0% |
| 1991 Q4 | -5.3 Million USD | -453.33% |
| 1991 Q1 | 1.1 Million USD | 120.37% |
| 1990 Q1 | 1.2 Million USD | 125.0% |
| 1990 Q3 | 1.4 Million USD | -12.5% |
| 1990 Q2 | 1.6 Million USD | 33.33% |
| 1990 Q4 | -5.4 Million USD | -485.71% |
| 1990 FY | -1 Million USD | -400.0% |
| 1989 Q3 | 1.5 Million USD | -6.25% |
| 1989 FY | -200 Thousand USD | 75.0% |
| 1989 Q4 | -4.8 Million USD | -420.0% |
| 1989 Q1 | 1.5 Million USD | 134.09% |
| 1989 Q2 | 1.6 Million USD | 6.67% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Bionano Genomics, Inc. | -215.24 Million USD | 127.254% |
| Prenetics Global Limited | -52.51 Million USD | 211.71% |
| Star Equity Holdings, Inc. | -4.34 Million USD | 1449.816% |
| CareDx, Inc | -101.9 Million USD | 157.569% |
| Exact Sciences Corporation | -215.01 Million USD | 127.284% |
| Exagen Inc. | -22.83 Million USD | 356.877% |
| Inotiv, Inc. | -81.46 Million USD | 172.014% |
| Guardant Health, Inc. | -564.72 Million USD | 110.388% |
| Biodesix, Inc. | -41.34 Million USD | 241.897% |
| BioNexus Gene Lab Corp. | -2.59 Million USD | 2361.847% |
| Precipio, Inc. | -7.62 Million USD | 869.856% |
| iSpecimen Inc. | -11.16 Million USD | 625.214% |
| Natera, Inc. | -446.24 Million USD | 113.146% |
| Aspira Women's Health Inc. | -18.85 Million USD | 411.177% |
| Standard BioTools Inc. | -76.6 Million USD | 176.584% |
| 23andMe Holding Co. | -321.35 Million USD | 118.255% |
| Castle Biosciences, Inc. | -67.97 Million USD | 186.298% |
| Personalis, Inc. | -109.93 Million USD | 153.361% |
| Aclaris Therapeutics, Inc. | -97.35 Million USD | 160.256% |
| Applied DNA Sciences, Inc. | -10.95 Million USD | 635.574% |
| OpGen, Inc. | -15.68 Million USD | 473.924% |
| T2 Biosystems, Inc. | -49.66 Million USD | 218.12% |
| Myriad Genetics, Inc. | -123.7 Million USD | 147.424% |
| ICON Public Limited Company | 956.15 Million USD | 93.865% |
| NeoGenomics, Inc. | -107.73 Million USD | 154.451% |
| Star Equity Holdings, Inc. | -4.34 Million USD | 1449.816% |
| IDEXX Laboratories, Inc. | 1.09 Billion USD | 94.653% |
| RadNet, Inc. | 98.69 Million USD | 40.563% |
| MDxHealth SA | -27.32 Million USD | 314.67% |
| Psychemedics Corporation | -2.92 Million USD | 2108.319% |
| Illumina, Inc. | -1.06 Billion USD | 105.488% |
| Check-Cap Ltd. | -19.28 Million USD | 404.158% |
| Twist Bioscience Corporation | -220.83 Million USD | 126.565% |
| DarioHealth Corp. | -56.18 Million USD | 204.403% |
| Fulgent Genetics, Inc. | -72.69 Million USD | 180.697% |
| Sera Prognostics, Inc. | -39.82 Million USD | 247.317% |
| ENDRA Life Sciences Inc. | -10.52 Million USD | 657.594% |
| OPKO Health, Inc. | -157.02 Million USD | 137.36% |
| Medpace Holdings, Inc. | 336.82 Million USD | 82.584% |
| Intelligent Bio Solutions Inc. | -10.28 Million USD | 670.476% |
| Prenetics Global Limited | -52.51 Million USD | 211.71% |
| Mainz Biomed B.V. | -26.64 Million USD | 320.168% |
| bioAffinity Technologies, Inc. | -7.97 Million USD | 835.75% |
| Trinity Biotech plc | -27.04 Million USD | 316.909% |
| Neuronetics, Inc. | -30.55 Million USD | 291.998% |
| Sotera Health Company | 276.69 Million USD | 78.798% |
| bioAffinity Technologies, Inc. | -7.97 Million USD | 835.75% |